HER2 NEGATIVE BREAST CANCER

HER2 NEGATIVE BREAST CANCER was reported 51 times

HER2 NEGATIVE BREAST CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RIBOCICLIB 21 0.0006
1 PAMIDRONATE DISODIUM 1 0.0003
2 PERTUZUMAB 7 0.0003
3 FULVESTRANT 8 0.0002
4 ANASTROZOLE TABLETS 5 0.0002
5 SACITUZUMAB GOVITECAN 1 0.0002
6 LETROZOLE TABLETS 10 0.0002
7 LETROZOLE 10 0.0002
8 ANASTROZOLE 5 0.0001
9 ADO-TRASTUZUMAB EMTANSINE 1 0.0001
10 EVEROLIMUS TABLETS 2 0.0001
11 EXEMESTANE 2 0.0001
12 TRASTUZUMAB 6 0.0001
13 DOCETAXEL ANHYDROUS 4 0.0001
14 DOCETAXEL 4 0.0001
15 GEMCITABINE HYDROCHLORIDE 3 0.0001
16 PACLITAXEL 5 0.0000
17 ABEMACICLIB 1 0.0000
18 ESTRADIOL TRANSDERMAL 2 0.0000
19 EVEROLIMUS 2 0.0000
20 CISPLATIN 3 0.0000
21 MESALAMINE 1 0.0000
22 ESTRADIOL 3 0.0000
23 CAPECITABINE 3 0.0000
24 OFATUMUMAB 1 0.0000
25 CLARITHROMYCIN 1 0.0000
26 IXEKIZUMAB 1 0.0000
27 FILGRASTIM 1 0.0000
28 ZOLEDRONIC ACID 1 0.0000
29 DIVALPROEX SODIUM 1 0.0000
30 PALBOCICLIB 2 0.0000
31 DENOSUMAB 4 0.0000
32 FINGOLIMOD HCL 1 0.0000
33 DOXORUBICIN 1 0.0000
34 PEMBROLIZUMAB 1 0.0000
35 BEVACIZUMAB 1 0.0000
36 BISOPROLOL FUMARATE 1 0.0000
37 HYDROCHLOROTHIAZIDE 1 0.0000
38 SECUKINUMAB 1 0.0000
39 LOSARTAN 1 0.0000
40 RANITIDINE 1 0.0000
41 FOLIC ACID 1 0.0000
42 ETANERCEPT 1 0.0000
43 ADALIMUMAB 1 0.0000